| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
25,396 |
25,347 |
$1.79M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
22,331 |
20,966 |
$1.34M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
20,806 |
19,651 |
$739K |
| 31231 |
|
8,619 |
8,487 |
$710K |
| 31575 |
|
4,715 |
4,655 |
$265K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
8,550 |
6,863 |
$258K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
6,705 |
6,520 |
$233K |
| 95024 |
|
1,519 |
1,515 |
$206K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
8,114 |
6,185 |
$195K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
3,501 |
3,481 |
$195K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
6,984 |
5,416 |
$189K |
| 95004 |
Percutaneous tests with allergenic extracts, immediate type reaction |
2,156 |
2,113 |
$156K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
1,731 |
1,537 |
$150K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
3,722 |
3,173 |
$135K |
| 31237 |
|
1,019 |
896 |
$127K |
| 92557 |
|
6,104 |
6,074 |
$116K |
| 95165 |
Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials |
658 |
623 |
$76K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
12,621 |
9,680 |
$73K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
5,922 |
4,731 |
$72K |
| 99215 |
Prolong outpt/office vis |
803 |
766 |
$67K |
| 30520 |
|
257 |
256 |
$59K |
| 92550 |
|
6,122 |
6,099 |
$49K |
| 69210 |
|
2,446 |
2,269 |
$47K |
| 70486 |
|
585 |
566 |
$38K |
| 92612 |
|
363 |
363 |
$36K |
| 92587 |
|
3,596 |
3,588 |
$34K |
| 31579 |
|
318 |
313 |
$28K |
| 92540 |
|
494 |
494 |
$27K |
| 95117 |
|
4,218 |
1,537 |
$25K |
| 42820 |
Tonsillectomy and adenoidectomy; younger than age 12 |
171 |
171 |
$24K |
| 99205 |
Prolong outpt/office vis |
233 |
233 |
$23K |
| 30140 |
|
349 |
343 |
$18K |
| 92524 |
|
299 |
292 |
$16K |
| 92537 |
|
460 |
459 |
$15K |
| 99442 |
|
1,347 |
1,092 |
$14K |
| 99305 |
|
365 |
357 |
$12K |
| 95992 |
|
645 |
622 |
$12K |
| 97162 |
|
239 |
238 |
$11K |
| 92526 |
|
181 |
151 |
$9K |
| 99223 |
Prolong inpt eval add15 m |
102 |
97 |
$9K |
| 92610 |
|
231 |
225 |
$8K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
557 |
457 |
$8K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
403 |
333 |
$7K |
| 95800 |
|
138 |
136 |
$7K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
415 |
355 |
$6K |
| 99308 |
Subsequent nursing facility care, per day, straightforward |
257 |
252 |
$5K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
438 |
359 |
$5K |
| 70480 |
|
76 |
76 |
$5K |
| 30802 |
|
83 |
81 |
$5K |
| K1034 |
Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count |
694 |
610 |
$3K |
| 99309 |
Subsequent nursing facility care, per day, low to moderate complexity |
90 |
90 |
$3K |
| 92553 |
|
200 |
200 |
$3K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
102 |
75 |
$3K |
| 92591 |
|
267 |
264 |
$2K |
| 30901 |
|
27 |
26 |
$2K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
18 |
16 |
$1K |
| 99304 |
|
30 |
30 |
$1K |
| 0001A |
|
30 |
30 |
$1K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
67 |
65 |
$900.20 |
| 0002A |
|
24 |
23 |
$790.00 |
| 95115 |
|
145 |
58 |
$627.40 |
| 99441 |
|
106 |
94 |
$545.88 |
| 99306 |
Prolong nursin fac eval 15m |
13 |
13 |
$404.81 |
| 99422 |
|
18 |
17 |
$354.57 |
| 69200 |
|
16 |
15 |
$138.02 |
| 97035 |
|
18 |
14 |
$105.10 |
| G2024 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]) from an individual in a snf or by a laboratory on behalf of a hha, any specimen source |
14 |
13 |
$101.84 |
| G2012 |
Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion |
15 |
15 |
$88.65 |
| 92567 |
|
14 |
14 |
$63.87 |